Welcome to LookChem.com Sign In | Join Free   Post buying lead  Chemical Tools
Post Buying Lead

Basic information

  • Name:
  • 3,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, 3-methyl 5-(2-methylpropyl)ester

  • Superlist Name:
  • Nisoldipine
  • CAS No.:
  • 63675-72-9

  • Formula:
  • C20H24N2O6
  • Synonyms:
  • 3,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, methyl 2-methylpropyl ester(9CI);BAY-k 5552;Baymycard;Geomatrix 16E;Nisocor;Nisoldipin;Sular;Syscor;Zadipina;
Home > Hot Product_List > Nisoldipine
Supplier Location:
China (Mainland)(32)United States(2)Canada(1)Italy(1)
Business Type:
Importer/Exporter(28)Lab/Research institutions(3)Manufacturers(2)Other(2)
Certificates:
Production License(2)ISO(1)

Please post your buying leads,so that our qualified suppliers will soon contact you!
*Required Fields

Specification

The IUPAC name of Nisoldipine is 3-O-methyl 5-O-(2-methylpropyl)2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate. With the CAS registry number 63675-72-9, it is also named as 1,4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 2-methylpropyl ester. The product's categories are Active Pharmaceutical Ingredients; All Inhibitors; Inhibitors; Intermediates & Fine Chemicals; Pharmaceuticals; Calcium Channel. Besides, it is light tan crystals, which should be stored in sealed containers in a cool, dry place away from oxidizing agents. In addition, its molecular formula is C20H24N2O6 and molecular weight is 388.42.

The other characteristics of this product can be summarized as: (1)EINECS: 264-407-7; (2)ACD/LogP: 4.38; (3)# of Rule of 5 Violations: 0; (4)ACD/LogD (pH 5.5): 4.38; (5)ACD/LogD (pH 7.4): 4.38; (6)ACD/BCF (pH 5.5): 1244.48; (7)ACD/BCF (pH 7.4): 1246.28; (8)ACD/KOC (pH 5.5): 5712.31; (9)ACD/KOC (pH 7.4): 5720.55; (10)#H bond acceptors: 8; (11)#H bond donors: 1; (12)#Freely Rotating Bonds: 8; (13)Index of Refraction: 1.544; (14)Molar Refractivity: 101.76 cm3; (15)Molar Volume: 322.1 cm3; (16)Surface Tension: 43.5 dyne/cm; (17)Density: 1.205 g/cm3; (18)Flash Point: 258.2 °C; (19)Melting Point: 147-148 °C; (20)Water Solubility: 24.6 mg/L at 25 °C; (21)Enthalpy of Vaporization: 77.25 kJ/mol; (22)Boiling Point: 503.3 °C at 760 mmHg; (23)Vapour Pressure: 2.95E-10 mmHg at 25 °C.

Preparation of Nisoldipine: frist, you can use o-Nitrobenzaldehyde to react with Isobutyl acetoacetate. And then use the resultant to react with Methyl 3-amino-2-butenoate by heating for 20 hours.

Uses of Nisoldipine: this chemical is a calcium channel blocker of the dihydropyridine class that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina. Similarly, it can be used to produce 2,6-Dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 2-methylpropyl ester.



This reaction needs 20percent aq. HNO3 at temperature of 100 °C for 1 hour. The yield is 63 %.

People can use the following data to convert to the molecule structure.
(1)SMILES: O=C(OCC(C)C)\C1=C(\N/C(=C(/C(=O)OC)C1c2ccccc2[N+]([O-])=O)C)C
(2)InChI: InChI=1/C20H24N2O6/c1-11(2)10-28-20(24)17-13(4)21-12(3)16(19(23)27-5)18(17)14-8-6-7-9-15(14)22(25)26/h6-9,11,18,21H,10H2,1-5H3
(3)InChIKey: VKQFCGNPDRICFG-UHFFFAOYAI

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 intravenous 2mg/kg (2mg/kg)   New Drugs Annual: Cardiovascular Drugs. Vol. 1, Pg. 243, 1983.
dog LD50 oral 400mg/kg (400mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 23, Pg. 682, 1992.
mouse LD50 intravenous 360ug/kg (0.36mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES

SKIN AND APPENDAGES (SKIN): HAIR: OTHER
Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 3285, 1988.
mouse LD50 oral 411mg/kg (411mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

LUNGS, THORAX, OR RESPIRATION: CYANOSIS
Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 3285, 1988.
mouse LD50 subcutaneous 384mg/kg (384mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

SKIN AND APPENDAGES (SKIN): HAIR: OTHER
Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 3285, 1988.
rabbit LD50 intravenous 2500ug/kg (2.5mg/kg)   New Drugs Annual: Cardiovascular Drugs. Vol. 1, Pg. 243, 1983.
rabbit LD50 oral > 5gm/kg (5000mg/kg)   New Drugs Annual: Cardiovascular Drugs. Vol. 1, Pg. 243, 1983.
rat LD50 intravenous 1120ug/kg (1.12mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 3285, 1988.
rat LD50 oral 1257mg/kg (1257mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

LUNGS, THORAX, OR RESPIRATION: CYANOSIS
Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 3285, 1988.
rat LD50 subcutaneous 674mg/kg (674mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

SKIN AND APPENDAGES (SKIN): HAIR: OTHER
Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 3285, 1988.

©2008 LookChem.com,License:ICP NO.:Zhejiang10014259

[Hangzhou]86-571-85317600,85317603,85317620